Clinical trial NCT03018236 - References

Cocaine Addiction — Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.

Citation(s)

•   Agrawal A, Verweij KJ, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, Nelson EC, Slutske WS, Whitfield JB, Lynskey MT
  The genetics of addiction-a translational perspective. Transl Psychiatry. 2012 Jul 17;2:e140. doi: 10.1038/tp.2012.54. Review. Erratum in: Transl Psychiatry. 2012;2:e193.
•   Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, Comim CM, Cassini C, Stertz L, Ribeiro LC, Quevedo J, Kapczinski F, Berk M, Gonçalves CA
  DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1282-8.
•   Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group
  . Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007 Apr;8(4):292-3.
•   Baker DA, McFarland K, Lake RW, Shen H, Toda S, Kalivas PW
  N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann N Y Acad Sci. 2003 Nov;1003:349-51.
•   Berk M, Malhi GS, Gray LJ, Dean OM
  The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013 Mar;34(3):167-77. doi: 10.1016/j.tips.2013.01.001. Review.
•   Bibel M, Barde YA
  Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000 Dec 1;14(23):2919-37. Review.
•   Calado RT, Young NS
  Telomere diseases. N Engl J Med. 2009 Dec 10;361(24):2353-65. doi: 10.1056/NEJMra0903373. Review.
•   Chen CH, Pan CH, Chen CC, Huang MC
  Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity. Alcohol Clin Exp Res. 2011 Feb;35(2):338-44. doi: 10.1111/j.1530-0277.2010.01349.x.
•   Corominas-Roso M, Roncero C, Daigre C, Grau-Lopez L, Ros-Cucurull E, Rodríguez-Cintas L, Sanchez-Mora C, Lopez MV, Ribases M, Casas M
  Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients. Psychiatry Res. 2015 Feb 28;225(3):309-14. doi: 10.1016/j.psychres.2014.12.019.
•   Costa MA, Girard M, Dalmay F, Malauzat D
  Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin Exp Res. 2011 Nov;35(11):1966-73. doi: 10.1111/j.1530-0277.2011.01548.x.
•   Cross CE, Valacchi G, Schock B, Wilson M, Weber S, Eiserich J, van der Vliet A
  Environmental oxidant pollutant effects on biologic systems: a focus on micronutrient antioxidant-oxidant interactions. Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 2):S44-50. Review.
•   Davis MI
  Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther. 2008 Apr;118(1):36-57. doi: 10.1016/j.pharmthera.2008.01.003. Review.
•   de Lima Osório F, Crippa JA, Loureiro SR
  Further psychometric study of the Beck Anxiety Inventory including factorial analysis and social anxiety disorder screening. Int J Psychiatry Clin Pract. 2011 Nov;15(4):255-62. doi: 10.3109/13651501.2011.605955.
•   Dean O, Giorlando F, Berk M
  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. Review.
•   Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, Kirk G, Hall WD
  Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011 Jan 15;113(2-3):88-95. doi: 10.1016/j.drugalcdep.2010.07.026. Review.
•   Ersche KD, Jones PS, Williams GB, Robbins TW, Bullmore ET
  Cocaine dependence: a fast-track for brain ageing? Mol Psychiatry. 2013 Feb;18(2):134-5. doi: 10.1038/mp.2012.31.
•   Frey BN, Valvassori SS, Gomes KM, Martins MR, Dal-Pizzol F, Kapczinski F, Quevedo J
  Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 2006 Jun 30;1097(1):224-9.
•   Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV
  Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557. Review.
•   Grant JE, Odlaug BL, Kim SW
  A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol. 2010 Nov;20(11):823-8. doi: 10.1016/j.euroneuro.2010.06.018.
•   Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, McRae-Clark AL, Brady KT
  A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug;169(8):805-12. doi: 10.1176/appi.ajp.2012.12010055. Erratum in: Am J Psychiatry. 2012 Aug 1;169(8):869.
•   Gray KM, Watson NL, Carpenter MJ, Larowe SD
  N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr;19(2):187-9. doi: 10.1111/j.1521-0391.2009.00027.x.
•   Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD
  Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000 Feb 1;58(1-2):55-66.
•   Haile CN, Kosten TR, Kosten TA
  Genetics of dopamine and its contribution to cocaine addiction. Behav Genet. 2007 Jan;37(1):119-45. Review.
•   Huang MC, Chen CC, Peng FC, Tang SH, Chen CH
  The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):66-9. doi: 10.1016/j.pnpbp.2008.10.009.
•   Huang MC, Chen CH, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ
  Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol. 2008 May-Jun;43(3):241-5. doi: 10.1093/alcalc/agm172.
•   Huang MC, Chen CH, Liu HC, Chen CC, Ho CC, Leu SJ
  Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res. 2011 Jan;35(1):126-31. doi: 10.1111/j.1530-0277.2010.01329.x.
•   Jaffe JH
  Trivializing dependence. Br J Addict. 1990 Nov;85(11):1425-7; discussion 1429-31.
•   Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC
  Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014 May 14;311(18):1889-900. doi: 10.1001/jama.2014.3628. Review.
•   Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, Epperson LE
  Reliability and validity of the Cocaine Selective Severity Assessment. Addict Behav. 1998 Jul-Aug;23(4):449-61.
•   Kendler KS, Ohlsson H, Maes HH, Sundquist K, Lichtenstein P, Sundquist J
  A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men. Drug Alcohol Depend. 2015 Apr 1;149:49-54. doi: 10.1016/j.drugalcdep.2015.01.016.
•   Kenward MG
  Selection models for repeated measurements with non-random dropout: an illustration of sensitivity. Stat Med. 1998 Dec 15;17(23):2723-32.
•   Kessler F, Cacciola J, Alterman A, Faller S, Souza-Formigoni ML, Cruz MS, Brasiliano S, Pechansky F
  Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Rev Bras Psiquiatr. 2012 Mar;34(1):24-33.
•   Laird NM
  Missing data in longitudinal studies. Stat Med. 1988 Jan-Feb;7(1-2):305-15.
•   LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, Saladin M, McRae A, Brady K
  Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb;15(1):105-10.
•   LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW, Malcolm R
  Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul;164(7):1115-7.
•   Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST
  A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006 Feb;101(2):192-203. Review.
•   Lynskey MT, Agrawal A, Henders A, Nelson EC, Madden PA, Martin NG
  An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology. Twin Res Hum Genet. 2012 Oct;15(5):631-41. doi: 10.1017/thg.2012.41.
•   Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ
  An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):389-94.
•   McGinty JF, Mendelson JE
  Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes? Biol Psychiatry. 2011 Oct 15;70(8):700-1. doi: 10.1016/j.biopsych.2011.08.017.
•   McGinty JF, Whitfield TW Jr, Berglind WJ
  Brain-derived neurotrophic factor and cocaine addiction. Brain Res. 2010 Feb 16;1314:183-93. doi: 10.1016/j.brainres.2009.08.078. Review.
•   McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP
  A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis. 1992 Feb;180(2):101-10.
•   McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M
  The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
•   Nestler EJ
  From neurobiology to treatment: progress against addiction. Nat Neurosci. 2002 Nov;5 Suppl:1076-9. Review.
•   Nestler EJ
  The neurobiology of cocaine addiction. Sci Pract Perspect. 2005 Dec;3(1):4-10. Review.
•   Olive MF, Cleva RM, Kalivas PW, Malcolm RJ
  Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Review.
•   Patriquin MA, Bauer IE, Soares JC, Graham DP, Nielsen DA
  Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet. 2015 Oct;25(5):181-93. doi: 10.1097/YPG.0000000000000095. Review.
•   Pavanello S, Hoxha M, Dioni L, Bertazzi PA, Snenghi R, Nalesso A, Ferrara SD, Montisci M, Baccarelli A
  Shortened telomeres in individuals with abuse in alcohol consumption. Int J Cancer. 2011 Aug 15;129(4):983-92. doi: 10.1002/ijc.25999.
•   Prendergast M, Podus D, Finney J, Greenwell L, Roll J
  Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006 Nov;101(11):1546-60. Review.
•   Rabkin JG, Markowitz JS, Ocepek-Welikson K, Wager SS
  General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol. 1992 Feb;12(1):3-10.
•   Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E
  Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007 Jun 7;3:5.
•   Sansone RA, Sansone LA
  Getting a Knack for NAC: N-Acetyl-Cysteine. Innov Clin Neurosci. 2011 Jan;8(1):10-4.
•   Santos Cruz M, Andrade T, Bastos FI, Leal E, Bertoni N, Villar LM, Tiesmaki M, Fischer B
  Key drug use, health and socio-economic characteristics of young crack users in two Brazilian cities. Int J Drug Policy. 2013 Sep;24(5):432-8. doi: 10.1016/j.drugpo.2013.03.012.
•   Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W
  Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur Addict Res. 2011;17(4):211-6. doi: 10.1159/000327682.
•   Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE
  N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology. 2012 Aug;37(9):2143-52. doi: 10.1038/npp.2012.66.
•   Schneider R Jr, Santos CF, Clarimundo V, Dalmaz C, Elisabetsky E, Gomez R
  N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats. Alcohol. 2015 May;49(3):259-63. doi: 10.1016/j.alcohol.2015.01.009.
•   Shen Q, Zhao X, Yu L, Zhang Z, Zhou D, Kan M, Zhang D, Cao L, Xing Q, Yang Y, Xu H, He L, Liu Y
  Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations. J Clin Endocrinol Metab. 2012 Apr;97(4):1371-4. doi: 10.1210/jc.2011-1562.
•   Sinha R
  New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 2011 Oct;13(5):398-405. doi: 10.1007/s11920-011-0224-0. Review.
•   Skinner MD, Lahmek P, Pham H, Aubin HJ
  Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS One. 2014 Feb 10;9(2):e87366. doi: 10.1371/journal.pone.0087366.
•   Sordi AO, Pechansky F, Kessler FH, Kapczinski F, Pfaffenseller B, Gubert C, de Aguiar BW, de Magalhães Narvaez JC, Ornell F, von Diemen L
  Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Psychopharmacology (Berl). 2014 Oct;231(20):4031-9. doi: 10.1007/s00213-014-3542-1.
•   Spencer RL, Hutchison KE
  Alcohol, aging, and the stress response. Alcohol Res Health. 1999;23(4):272-83.
•   Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM
  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989 Nov;84(11):1353-7.
•   Urbanska EM, Czuczwar SJ, Kleinrok Z, Turski WA
  Excitatory amino acids in epilepsy. Restor Neurol Neurosci. 1998;13(1-2):25-39.
•   Verdejo-García A, Pérez-García M
  Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl). 2007 Mar;190(4):517-30.
•   Volkow ND, Koob G, Baler R
  Biomarkers in substance use disorders. ACS Chem Neurosci. 2015 Apr 15;6(4):522-5. doi: 10.1021/acschemneuro.5b00067. Review.
•   von Diemen L, Kapczinski F, Sordi AO, de Magalhães Narvaez JC, Guimarães LS, Kessler FH, Pfaffenseller B, de Aguiar BW, de Moura Gubert C, Pechansky F
  Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. Int J Neuropsychopharmacol. 2014 Jan;17(1):33-40. doi: 10.1017/S146114571300103X.
•   Walker J, Winhusen T, Storkson JM, Lewis D, Pariza MW, Somoza E, Somoza V
  Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study. Hum Psychopharmacol. 2014 Nov;29(6):537-43.
•   Wei LJ, Lachin JM
  Properties of the urn randomization in clinical trials. Control Clin Trials. 1988 Dec;9(4):345-64. Erratum in: Controlled Clin Trials 1989 Mar;10(1):following 126.
•   Wu Y, Pan X, Zhang S, Wang W, Cai M, Li Y, Yang F, Guo H
  Protective effect of corn peptides against alcoholic liver injury in men with chronic alcohol consumption: a randomized double-blind placebo-controlled study. Lipids Health Dis. 2014 Dec 13;13:192. doi: 10.1186/1476-511X-13-192.
•   Yang Z, Ye J, Li C, Zhou D, Shen Q, Wu J, Cao L, Wang T, Cui D, He S, Qi G, He L, Liu Y
  Drug addiction is associated with leukocyte telomere length. Sci Rep. 2013;3:1542. doi: 10.1038/srep01542.
•   Zaparte A, Viola TW, Grassi-Oliveira R, da Silva Morrone M, Moreira JC, Bauer ME
  Early abstinence of crack-cocaine is effective to attenuate oxidative stress and to improve antioxidant defences. Psychopharmacology (Berl). 2015 Apr;232(8):1405-13. doi: 10.1007/s00213-014-3779-8.
•   Zhou W, Kalivas PW
  N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol Psychiatry. 2008 Feb 1;63(3):338-40.

The Effect of N-acetylcysteine (NAC) on Treatment of Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.

Details for clinical trial NCT03018236